Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akseli Hemminki

Showing results (61-70 of 280) with videos related to

Pageof 28
Sort By:
International Journal of Cancer|April 16, 2022
Long-term incidence in hepatocellular carcinoma and intrahepatic bile duct cancer in Denmark, Finland, Norway and Sweden, role of Thorotrast?Kari Hemminki, Filip Tichanek, Asta Försti, et al.
Cancer Medicine|November 28, 2018
Second primary cancer after female breast cancer: Familial risks and cause of deathGuoqiao Zheng, Akseli Hemminki, Asta Försti, et al.
Cancers|September 10, 2021
Familial Risks and Proportions Describing Population Landscape of Familial CancerKari Hemminki, Kristina Sundquist, Jan Sundquist, et al.
The Journal of Gene Medicine|March 11, 2005
VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion constructTanja Hakkarainen, Tiina Wahlfors, Outi Meriläinen, et al.
Clinical Epidemiology|August 22, 2020
Incidence Differences Between First Primary Cancers and Second Primary Cancers Following Skin Squamous Cell Carcinoma as Etiological CluesGuoqiao Zheng, Kristina Sundquist, Jan Sundquist, et al.
The Journal of Investigative Dermatology|July 10, 2019
Second Primary Cancers in Patients with Invasive and In Situ Squamous Cell Skin Carcinoma, Kaposi Sarcoma, and Merkel Cell Carcinoma: Role for Immune Mechanisms?Subhayan Chattopadhyay, Akseli Hemminki, Asta Försti, et al.
Journal of Virology|September 19, 2008
Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNAErkko Ylösmäki, Tanja Hakkarainen, Akseli Hemminki, et al.
International Journal of Cancer|August 13, 2017
Familial associations of female breast cancer with other cancersGuoqiao Zheng, Hongyao Yu, Akseli Hemminki, et al.
International Journal of Cancer|December 26, 2022
Long-term survival trends in solid cancers in the Nordic countries marking timing of improvementsKari Hemminki, Asta Försti, Vaclav Liska, et al.
JNCI Cancer Spectrum|July 31, 2019
Familial Risks and Mortality in Second Primary Cancers in MelanomaSubhayan Chattopadhyay, Akseli Hemminki, Asta Försti, et al.
Pageof 28

Showing results (61-70 of 280) with videos related to

Sort By:
Pageof 28
International Journal of Cancer|April 16, 2022
Long-term incidence in hepatocellular carcinoma and intrahepatic bile duct cancer in Denmark, Finland, Norway and Sweden, role of Thorotrast?Kari Hemminki, Filip Tichanek, Asta Försti, et al.
Cancer Medicine|November 28, 2018
Second primary cancer after female breast cancer: Familial risks and cause of deathGuoqiao Zheng, Akseli Hemminki, Asta Försti, et al.
Cancers|September 10, 2021
Familial Risks and Proportions Describing Population Landscape of Familial CancerKari Hemminki, Kristina Sundquist, Jan Sundquist, et al.
The Journal of Gene Medicine|March 11, 2005
VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion constructTanja Hakkarainen, Tiina Wahlfors, Outi Meriläinen, et al.
Clinical Epidemiology|August 22, 2020
Incidence Differences Between First Primary Cancers and Second Primary Cancers Following Skin Squamous Cell Carcinoma as Etiological CluesGuoqiao Zheng, Kristina Sundquist, Jan Sundquist, et al.
The Journal of Investigative Dermatology|July 10, 2019
Second Primary Cancers in Patients with Invasive and In Situ Squamous Cell Skin Carcinoma, Kaposi Sarcoma, and Merkel Cell Carcinoma: Role for Immune Mechanisms?Subhayan Chattopadhyay, Akseli Hemminki, Asta Försti, et al.
Journal of Virology|September 19, 2008
Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNAErkko Ylösmäki, Tanja Hakkarainen, Akseli Hemminki, et al.
International Journal of Cancer|August 13, 2017
Familial associations of female breast cancer with other cancersGuoqiao Zheng, Hongyao Yu, Akseli Hemminki, et al.
International Journal of Cancer|December 26, 2022
Long-term survival trends in solid cancers in the Nordic countries marking timing of improvementsKari Hemminki, Asta Försti, Vaclav Liska, et al.
JNCI Cancer Spectrum|July 31, 2019
Familial Risks and Mortality in Second Primary Cancers in MelanomaSubhayan Chattopadhyay, Akseli Hemminki, Asta Försti, et al.
Pageof 28